This statistic shows the expenditure on research and development by Aurobindo Pharma Limited in fiscal year 2017 and fiscal year 2018, by type. In fiscal year 2018, Aurobindo Pharma spent around 0.6 billion Indian rupees on capital expenses for research and development, while recurring expenses for R&D were more than 5.9 billion rupees in the same year.
Expenditure on R&D by Aurobindo Pharma Limited 2016-2018 by type
Expenditure on research and development by Aurobindo Pharma Limited in FY 2017 and FY 2018, by type
(in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Share of revenue from EU formulations of Aurobindo Pharma Limited 2012-2018
- Share of revenue from ARV formulations of Aurobindo Pharma Limited 2012-2018
- Revenue from growth market formulations of Aurobindo Pharma Limited 2012-2018
- Share of revenue from growth market formulations of Aurobindo Pharma 2012-2018
- Revenue from U.S. formulations of Aurobindo Pharma Limited 2012-2018
- Share of revenue from U.S. formulations of Aurobindo Pharma Limited 2012-2018
- Revenue from EU formulations of Aurobindo Pharma Limited 2012-2018
- Revenue from ARV formulations of Aurobindo Pharma Limited 2012-2018
- EBITDA of Aurobindo Pharma Limited in India 2012-2018
- Number of Aurobindo Pharma Limited's ANDAs in India by therapy FY 2018
- Share of revenue of Aurobindo Pharma Limited in India FY 2018, by type
- Share of EBITDA margin of Aurobindo Pharma Limited in India 2012-2018
- Revenue of Aurobindo Pharma Limited in India 2012-2019
- Net profits of Aurobindo Pharma Limited in India 2012-2018
- Net debt to EBITDA ratio of Aurobindo Pharma Limited in India 2012-2018
- Market size therapy drugs Aurobindo Pharma Limited in India by type FY 2018
- Net debt to equity ratio of Aurobindo Pharma Limited in India 2012-2018
- Daiichi Sankyo's total assets FY 2012-2017
- Diluted EPS for Dr. Reddy's Laboratories Limited 2013-2019
Aurobindo Pharma. (April 8, 2018). Expenditure on research and development by Aurobindo Pharma Limited in FY 2017 and FY 2018, by type (in billion Indian rupees) [Graph]. In Statista. Retrieved December 07, 2019, from https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. "Expenditure on research and development by Aurobindo Pharma Limited in FY 2017 and FY 2018, by type (in billion Indian rupees) ." Chart. April 8, 2018. Statista. Accessed December 07, 2019. https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. (2018). Expenditure on research and development by Aurobindo Pharma Limited in FY 2017 and FY 2018, by type (in billion Indian rupees) . Statista. Statista Inc.. Accessed: December 07, 2019. https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. "Expenditure on Research and Development by Aurobindo Pharma Limited in Fy 2017 and Fy 2018, by Type (in Billion Indian Rupees) ." Statista, Statista Inc., 8 Apr 2018, https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma, Expenditure on research and development by Aurobindo Pharma Limited in FY 2017 and FY 2018, by type (in billion Indian rupees) Statista, https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/ (last visited December 07, 2019)